STUDY QUESTION: Is there any association between serum 25-OH vitamin D levels and ovarian reserve markers in infertile women?
Introduction
The biologic actions of vitamin D are exerted through a soluble protein, the vitamin D receptor (VDR) that has been identified in many reproductive organs, including granulosa cells (Kinuta et al., 2000) . This diverse expression of VDR suggests a potential role of vitamin D in female reproduction and infertility (Fabris et al., 2014; Polyzos et al., 2014; Franasiak et al., 2015; van de Vijver et al., 2016) .
Although little is known about the mechanism by which vitamin D may affect reproductive physiology, a direct effect of vitamin D in ovarian steroidogenesis has been suggested. The evidence derives from several animal studies which have demonstrated that VDR null mutant mice have impaired folliculogenesis, with significantly lower oestrogens levels, compared to heterozygous mice (Yoshizawa et al., 1997) , with confirmatory results from human cell-line studies showing that vitamin D stimulates steroidogenesis in ovarian cells (Parikh et al., 2010) .
One of most important biomarkers produced by the granulosa cells, which actually has a crucial role in folliculogenesis, is anti-Mullerian hormone (AMH), given that it regulates the development of early preantaral and small antral follicles. Taking into account that accumulating results support a potential role of vitamin D during follicular development, several investigators have assessed the association of vitamin D with AMH in animal models (Dicken et al., 2012) and through experiments in human granulosa cells , showing that vitamin D affects AMH signalling.
Nevertheless, although the results from basic research are consistent enough to imply a relationship between vitamin D and AMH, the data from clinical studies are strongly contradictory, with some studies supporting an association between vitamin D and ovarian reserve (Dennis et al., 2012; Merhi et al., 2012) , and others failing to identify any significant correlation between vitamin D and AMH levels (Pearce et al., 2015) .
Taking into account the above-mentioned conflicting evidence, and the increasing interest regarding the role of vitamin D in female reproduction, we aimed to perform the first and largest prospective cross-sectional study evaluating the relationship between the most important ovarian reserve markers, serum AMH and antral follicle count (AFC), and 25-OH-vitamin D levels in infertile women.
Materials and Methods
Institutional review board approval was obtained for the conducting the study from the Ethical Committee of Universitair Ziekenhuis Brussel (BUN 143201317805). All patients gave a written informed consent in order to participate in this study.
Patients' eligibility criteria
All infertile women between 18 and 42 years and who underwent their first consultation in UZ Brussel were eligible.
The following exclusion criteria were applied: (1) women taking vitamin D supplements or using medication for systematic disease and (2) women with a potential iatrogenic (e.g. ovarian surgery, gonadotoxic therapy) or known genetic cause of ovarian loss, given that this would not allow us to assess the actual relationship between vitamin deficiency and ovarian reserve
Study design
The study was designed as a prospective cross-sectional study including infertile women. All patients were recruited within a time interval of 12 months from the initiation of the study, before undergoing infertility treatment.
Patients, following detailed information about the study and written informed consent, participated by providing a blood sample on the day of their first consultation, irrespective of the day of the menstrual cycle. All women had serum AMH and vitamin D sampled on the same day.
In addition, detailed information regarding their age, BMI, season of the blood sampling, cause of infertility, smoking status and history of any factor that could have affected their ovarian reserve have been recorded.
Serum 25-OH vitamin D measurement
Li-heparin samples from all patients were obtained on the day of the first consultation for measurement of 25-OH vitamin D levels. Total plasma 25-OH vitamin D was measured with the Elecsys Vitamin D Total immunoassay on a Cobas6000 immunoanalyzer (Roche Diagnostics, Mannheim, Germany). Total imprecision coefficients of variance were 9.7% at a concentration level of 16.5 ng/mL and 5.9% at 31.7 ng/mL.
Ovarian reserve markers

Anti-Müllerian hormone measurement
Serum AMH samples were obtained at the first consultation, on the same day of 25-OH measurement, irrespective of the day of the menstrual cycle. Blood was drawn in plain serum tubes; centrifugation was performed within 1 h and serum was separated and immediately stored at −80°C until analysis. All samples were measured with the Gen II Beckman Coulter AMH ELISA kit. The AMH assay demonstrated stable intra-and inter-assay coefficients of variation <6% and a functional sensitivity of 0.16 ng/mL.
Antral follicle count
AFC was measured on the second or third day of the first cycle following blood sampling for the determination of AMH and 25-OH vitamin D levels. The recorded AFC represented the combined total of antral follicles between 2 and 10 mm from the left and the right ovary.
Main outcome measures
The primary outcome was the association between 25-OH vitamin D levels and ovarian reserve markers.
Statistical analysis
For descriptive statistics, continuous data are presented as mean ± SD and categorical data are described by number of cases, including numerator and denominator, and percentages. Continuous variables were analysed using the independent t-test or Mann-Whitney U-test depending on the normality of the distribution. Normality was examined by the use of the Shapiro-Wilk test. Categorical variables were analysed by Pearson's chisquared test or Fisher's exact test, as appropriate.
Vitamin D deficiency was defined as serum 25-OH vitamin D levels <20 ng/mL in accordance with the Institute of Medicine (IOM) and the Endocrine Society clinical practice guidelines (Holick et al., 2011; Rosen et al., 2012) . That cut-off of 20 and not 30 ng/mL was based on the fact that levels of serum 25-OH vitamin D >21-<30 ng/mL are considered insufficient levels of vitamin D for current clinical guidelines, without adverse clinical consequences. Seasons were defined prior to data processing according to the calendar definitions of the seasons for Europe with each season lasting 3 months: autumn: September 21-December 20; winter: December 21-March 20; Spring: March 21-June 20; summer: June 21-September 20, as previously described (Wunder et al., 2005) .
The association between 25(OH) vitamin D concentrations and log 10 AMH levels or AFC, after adjusting for potential confounders was examined by multivariate linear regression. The log transformation of AMH was performed in order to assess the plausibility of linear regression. All covariates (age, BMI, cause of infertility, smoking status, season) were simultaneously entered to the multivariate linear regression model to identify the regression coefficients for factors related to the log 10 AMH levels and to the AFC, respectively. The assumptions for the final model were successfully tested. All statistical tests used a two-tailed α of 0.05. Analyses were performed using STATA 13.0.
Sample size calculation
Given the observational nature of our study and the conflicting evidence for the association of vitamin D with ovarian reserve, a sample size calculation was not part of the initial design of our study. Nevertheless, our sample size of 283 patients has a power of more than 90% to detect a correlation between 25(OH)vitamin D levels and AMH (correlation coefficient r = 0.2), with a significance level (alpha) of 0.05 using a two-sided z-test. The correlation coefficient was assumed to be 0 under the null hypothesis and 0.2 under the alternative hypothesis. Sample size calculation was performed in STATA 13 statistical software. 
Results
Baseline characteristics
Overall, 283 consecutive infertile women, undergoing their first treatment cycle in UZ Brussel were included in the study.
Baseline and biochemical characteristics of the whole cohort and according to vitamin D status are presented in Table I .
Among all patients, 30.7% (n = 87) were vitamin D deficient (<20 ng/mL) whereas 69.3% (n = 196) had normal vitamin D levels (≥20 ng/mL).
The mean AMH and the median AFC levels did not differ significantly between the two groups: AMH 3.9 ng/mL (±3. reveal any significant difference for age, BMI, smoking status and infertility cause. The season of the blood sampling was the only variable, which differed significantly (P < 0.001) between the two groups.
Main outcomes
No correlation was observed between 25-OH vitamin D and AMH (spearman's r = 0.02, P value = 0.7) or AFC (spearman's r = -0.02, P value = 0.7) (Fig. 1) .
Multiple linear regression analysis was conducted in order to evaluate the relationship between serum 25-OH vitamin D levels and AMH levels or AFC, after adjusting for potential confounders (age, BMI, smoking status, infertility cause and season of blood sampling).
According to the adjusted analysis, the regression slope in all participants for total 25OH-D predicting log 10 AMH was 0.006 [standard error (SE) = 0.07, P value = 0.9] (Table II) . Similarly, no significant association was observed between AFC and vitamin D levels, even after controlling for relevant co-variants (regression coefficient -0.09. SE 0.08, P value = 0.2) ( Table III) .
Discussion
Although data from basic research indicate that vitamin D deficiency may have an effect on steroidogenesis and follicular development, our study, by prospectively recruiting a large number of infertile women, shows that vitamin D deficiency does not seem to have a detrimental effect on ovarian reserve. According to our results, vitamin D levels are not related to AMH and AFC, even after adjusting for relevant confounders, such as age, BMI, cause of infertility, seasonality and smoking status.
Regarding previous clinical studies supporting a relationship between vitamin D and AMH, we failed to replicate those results. In particular, Merhi et al. (2012) performed a cross-sectional nested study and demonstrated a weak significant positive correlation between serum 25(OH)vitamin D and AMH in late reproductive-aged women, although no association was found in younger patients. A potential explanation for the discrepancy between our results and the results by Mehri might be attributed to the retrospective nature of the data and limitations that can be associated with this, the fact that only noninfertile HIV infected women were included and only patients with available vitamin D data were analysed. Thus, the likelihood of selection bias might be higher. In the same context, Dennis et al. (2012) by analysing 33 premenopausal women, found that the seasonal change in AMH was correlated with the intial AMH level and the magnitude of change in vitamin D levels.
On the contrary, our study is in agreement with a prospective study of 67 patients, which tested the hypothesis that 1,25-dihydroxyvitamin D3 supplementation may normalize serum AMH levels in vitamin Ddeficient premenopausal women and failed to find any beneficial effect of vitamin D supplementation on serum AMH levels (Irani et al., 2014) . Similarly, a recent retrospective study including 340 women did not demonstrate any correlation between serum AMH and vitamin D levels, in either polycystic ovary syndrome (PCOS) or ovulatory patients (Pearce et al., 2015) . The biologic actions of vitamin D are exerted through VDR which is a member of the steroid/thyroid nuclear hormone receptor superfamily (Johnson and DeLuca, 2001) . The expression of VDR in granulosa cells (Kinuta et al., 2000) , along with the fact that the promoter region for the AMH gene contains a vitamin D response element (Malloy et al., 2009) , were key elements for the increasing interest regarding vitamin D, characterized by many as the new 'fertility vitamin'. Nevertheless, even if this assumption seems attractive, the clinical studies are strongly controversial and our results add more to the existing sparse evidence by failing to identify any significant correlation.
Our study has several strengths compared with previous reports. First of all, owing to its prospective design and the stringent inclusion criteria used in order to eliminate confounders that might have affected the ovarian reserve, the risk of confounding bias appears to be substantially lower compared with previously published studies. Secondly, not only did we evaluate AMH serum levels in association with 25-OH vitamin D, but we also assessed another important ovarian reserve marker, AFC (Jayaprakasan et al., 2010) , contrary to all of the previous studies. Furthermore, AMH and 25-OH vitamin D were measured on the same day, reflecting the actual status of both hormones, while in the vast majority of the aforementioned studies stored blood samples were used (Dennis et al., 2012; Merhi et al., 2012; Pearce et al., 2015) . The current study had a large sample size of 283 infertile patients, whereas most of the previous trials had substantially fewer patients included, increasing the risk of type II error. Finally, all samples were measured by the same AMH assay (Gen II assay) with premixing samples with assay buffer prior to plating. This should be highlighted, especially since that the stability of serum AMH in terms of sample-to-sample variability under specific assay conditions has been seriously questioned (Rustamov et al., 2012) .
However, we need to highlight several limitations, which need to be considered when interpreting our results. Firstly, ethnicity in relation to vitamin D status was not assessed, given that the vast majority of patients included in our study were Caucasian. Secondly, we omitted the measurement of vitamin D binding protein, taking into account that none of the previous studies has assessed vitamin D binding protein and that 25-OH vitamin D is a widely accepted biomarker for vitamin D (Hollis, 2004) . Thirdly, although there was no relationship between vitamin D and ovarian reserve markers even after adjustment for the cause of infertility, we should note that PCOS patients represented a minority of the study's population and thus conclusions cannot be drawn for this specific group of patients, especially if we take into account previous reports that have linked vitamin D deficiency and PCOS (Wehr et al., 2011; Lerchbaum et al., 2012) . Fourthly, although our large sample size was adequate to detect even small correlations, we cannot exclude that a very weak association or a nonlinear relation may exist between ovarian reserve markers and vitamin D. Nevertheless, even if this is the case, it is indeed questionable whether such a weak association would be of clinical relevance. Finally, we need to acknowledge that data used to generate the study findings are cross-sectional in nature. In this regard, we cannot generate or exclude any causal effect hypothesis, which could be better assessed in longitudinal studies (Dennis et al., 2012) .
In conclusion, allowing for the limitations mentioned above, the results of the current first prospective and largest study support that an association between vitamin D and ovarian reserve markers is unlikely to exist. In this regard, routine assessment of vitamin D status and vitamin D supplementation of deficient patients in an aim to delay loss of ovarian reserve seems meaningless, at least in ovulatory infertile women. Nevertheless, vitamin D may have a role in human reproduction and ongoing prospective and translational research projects are urgently needed in order to evaluate the potential effect of vitamin D deficiency on reproductive outcome mediated through either an effect on oocyte quality or on endometrial receptivity and embryo implantation.
